The CMO Leadership Awards

In cooperation with Life Science Leader, Nice Insight is pleased to announce the winners of the second
annual CMO Leadership Awards.

Nice Insight combines surveying of thousands of industry executives with other key analyses to
serve both partnering groups and facilitate better overall outsourcing collaborations. Life Science
Leader developed the annual CMO Leadership Awards to honor top performers based on responses
and better serve pharmaceutical and biopharmaceutical executives in their CMO vetting process.

R&D — Regulatory

Drug Life Cycle Stages: R&D, Formulated Drug Production
	Alkermes "Alkermes Contract Pharma Services are honoured to be recognised by our peers through this CMO Leadership Award. We have a proud history of quality with multiple regulatory authorities including the EMA and U.S. FDA, across our global sites. We strive to have the highest regulatory and quality standards, exemplified by our culture of ‘Building Quality’ in everything we do for our partners." James Botkin — SVP of Operations
Drug Life Cycle Stages: R&D, Drug Substance Production, Formulated Drug Production
	Almac Pharma Services "It is extremely encouraging that our customers regard Almac so highly in quality, innovation, productivity, regulatory, and reliability which is how we strive to be perceived through our core values and our overall aim of partnering to advance human health. Working with all the leaders in the pharmaceutical and biotech sectors our aim is to establish long-term partnerships and the fact that over 95% of our business is repeat is genuine evidence of our success." Alan Armstrong — CEO
Drug Life Cycle Stages: R&D, Drug Substance Production, Formulated Drug Production
	Cook Pharmica "There are many reasons why biopharmaceutical companies count on us to produce a consistently dependable product. First, we have a manufacturing facility with the right capabilities, equipment, and location, and a team of collaborative, experienced subject-matter experts. We have also put in place a flexible infrastructure with processes that allow for client customization and have strived as an organization to learn from our mistakes, becoming better listeners throughout the process." Cory Lewis — Vice President of Business Development & Marketing
Drug Life Cycle Stages: R&D, Formulated Drug Production
	Dow Pharmaceutical Sciences "Dow is very pleased to receive these awards. We are honored to be recognized for our efforts and to be highlighted as a premier semi-solid and liquid product development company. We have focused on meeting and exceeding our customers’ expectations for more than 34 years. Being acknowledged for innovation, reliability, and regulatory, speaks not only to our exceptional technical expertise, but to the quality service our entire organization provides to our clients." Karen Yu, Ph.D. — General Manager
Drug Life Cycle Stages: R&D, Drug Substance Production
	FujiFilm Diosynth Biotechnologies "In our first year of operation as Fujifilm Diosynth Biotechnologies, we are delighted to be recognized for our Regulatory reputation. Quality underpins everything we do to ensure patient safety and this is exemplified by our successful inspection history at both our US and UK sites. As a global leader in the contract development and manufacture of biopharmaceuticals, we look forward to building on this reputation." Stephen Spearman, Ph. D., MBA — President, FUJIFILM Diosynth Biotechnologies USA Inc.
Drug Life Cycle Stages: R&D, Drug Substance Production, Formulated Drug Production
	Gallus BioPharmaceuticals, LLC "Gallus is delighted to be recognized in the CMO Leadership Award for its innovation, productivity, and regulatory performance. Gallus is innovating with the first Xcellerex 2000L FlexFactoryTM installed in the U.S. to provide highly flexible clinical manufacturing capacity. Gallus’ productivity is epitomized by its ten year history of commercial manufacturing, with over 200 commercial batches of product manufactured for 75 countries. This is enabled by an outstanding regulatory record with a recent no-483 FDA inspection." Mark B. Gallus — President & CEO
Drug Life Cycle Stages: R&D, Drug Substance Production, Formulated Drug Production
	Goodwin Biotechnology, Inc. "We at GBI are honored to be recognized in three categories of the CMO Leadership Awards, and consider it a testament to the quality of our people and their dedication to our customers. Innovation: Our scientists consistently identify solutions to the most complex challenges. Regulatory: We focus on quality and compliance from cell line engineering through cGMP manufacturing of late-stage clinical trial material. Reliability: Our unique approach helps ensure that we meet and exceed client expectations on every project." Bansi K. Bhan — Interim CEO Goodwin Biotechnology, Inc
Drug Life Cycle Stages: R&D, Formulated Drug Production
	Haupt Pharma AG "Haupt Pharma is one of the largest European companies for pharmaceutical contract development and manufacturing. In manufacturing highly potent products, both product safety and employee safety are particularly important to us. This is ensured with our dedicated production area. Under the closed and high-containment principle, processing of highly efficient active ingredients is performed in a closed system. This significantly reduces the risk of contamination of the machine environment and ensures protection of the product, employees and the environment." Dr. Karl Heinz Brücher — COO of Haupt Pharma AG.
Drug Life Cycle Stages: R&D, Formulated Drug Production
	NextPharma Technologies LTD "Our strategy focuses on providing customer satisfaction and pivotal to this is consistent compliance with regulatory standards. We work with our customers, in partnership, to ensure that quality is ‘built in’ to the products, processes and services that we offer. Our teams have a reputation of openness and transparency. Our culture of continuous improvement facilitates our desire to apply regulatory guidance in a way that benefits our customers, our business and ensures continued regulatory success." Dr. Franck Latrille — CEO
Drug Life Cycle Stages: R&D, Formulated Drug Production
	Norwich Pharmaceuticals "At Norwich, we have dedicated ourselves to focus on our customers and the patients they serve. We understand that CMO Leadership Award recognition is directly tied to the success of our customers, and we are proud to be a reliable partner for all stages of the product lifecycle from product development to scale-up and commercial manufacturing through clinical services. Patients put trust into our customer’s products, and Norwich’s 125-year history of quality and compliance provides a foundation for that trust." Terry Novak — President
Drug Life Cycle Stages: R&D, Drug Substance Production, Formulated Drug Production
	Pfizer CenterSource "PCS is pleased to be recognized by Life Science Leader for our operational excellence in the areas of reliability, innovation, productivity, and regulatory. The award confirms the long-standing commitment of our business to establish strategic partnerships between our customers and Pfizer Global Supply. This award validates the confidence our customers have when working with PCS and assures them that they are dealing with a business that has very high standards and expectations as a trustworthy contract development and manufacturing organization." Cristin Grove — Director Contract Manufacturing, PCS
Drug Life Cycle Stages: R&D, Formulated Drug Production
	Pharma Tech Industries "Cohesive productivity is crucial for a start-to-finish CMO such as us, and the best assurance we can provide potential customers is a strong reputation built on regulatory compliance. For over 40 years, PTI has been serving the supply chain needs of leading global pharmaceutical and personal care companies with manufacturing, packaging, and molding services. Our experienced quality and regulatory personnel address a broad range of domestic and international regulatory environments including cosmetic, over-the-counter, prescription (Rx), and medical device." Carl Oberg — President
Drug Life Cycle Stages: R&D, Drug Substance Production, Formulated Drug Production
	Pharmatek Laboratories, Inc. "In this new pharma economy where outsourcing has become its own ecosystem of suppliers, consultants and partnerships, leadership in contract manufacturing is a matter of staying focused on what makes each manufacturing run successful. Bringing high quality people, facilities and systems to any project will yield a high quality product. While the business of pharma is ever-changing, the focus on quality is the undeniable core of success." Timothy Scott — President
Drug Life Cycle Stages: R&D, Drug Substance Production
	Porton Fine Chemicals "I am honored and proud of my colleagues to have been recognized by Life Science Leader Magazine. It is particularly rewarding to know that this award emanates from survey comments from our clients. It validates the hard work and strategic alignment we foster among all of our employees at Porton." Oliver Ju — President and CEO
Drug Life Cycle Stages: Drug Substance Production, Formulated Drug Production
	Pyramid Laboratories, Inc. "Our expertise and advanced technological environment allows us to provide the client with highly skilled individual attention, professional service, and documented high quality in the most efficient and cost effective manner. At PYRAMID we guarantee quality, performance and integrity combined with a personal commitment. " Medhat Gorgy — President & Chief Executive Officer
Drug Life Cycle Stages: R&D, Drug Substance Production
	SAFC "As a CMO, SAFC aims to be the supplier of choice in the market. Reliability, innovation, productivity, and regulatory are more than words to our customers. We try to keep that fact in mind at all times and complement that approach with a comprehensive solutions offering. This kind of customer recognition is a true testament to the quality of that solution working in perfect harmony with the fantastic team we have here at SAFC." Deborah Slagle — SAFC's Vice President of Marketing and R&D
Drug Life Cycle Stages: R&D, Drug Substance Production
	Sandoz GmbH "We are delighted to be a recipient of the 2012 CMO Leadership Awards and sincerely thank our customers for this honor. Sandoz is proud of its strong heritage in contract manufacturing services. We have over 60 years of experience in the manufacturing of fermentation-derived intermediates and APIs across various therapeutic areas – as well as process enzymes – and over 30 years of experience in development and manufacturing of recombinant proteins and peptides (microbial and mammalian). Central to our success are our talented people who take a collaborative approach with our customers by offering end-to end support by helping them develop and commercialize important medicines." Friedrich Nachtmann and Gerhard Santer — Head of Biotech Corporations and Head of Global Development & Strategy
Drug Life Cycle Stages: R&D, Drug Substance Production, Formulated Drug Production
	Therapure Biopharma "Once again, we are privileged to receive the CMO Leadership award and honoured to be recognized by biopharma executives surveyed by Nice Insight as a leader in all categories (quality, reliability, innovation, productivity, and regulatory). I would like to take this opportunity to thank all the employees of Therapure, whose daily contributions and diligence is the driving force behind our company’s success as well as our clients, without whom this would not have been possible." Nick Green — CEO
Drug Life Cycle Stages: R&D, Drug Substance Production, Formulated Drug Production
	Uman Pharma Inc. "We are very happy to have been bestowed this honor by Life Science Leader, especially since this CMO Leadership Award comes from within the industry. As a young company, we are extremely proud of our accomplishments to date and our mission has always been to provide excellence in both products and services. We recognize and are fortunate to have an experienced, professional and dedicated team that is committed to the highest pharmaceutical quality standards. To have and to bring a Uman touch is our motto and it drives us to attain new heights." Sylvain Duvernay — CEO
Drug Life Cycle Stages: R&D, Formulated Drug Production
	Xcelience "It is an honor to be recognized by with top rankings in productivity and regulatory by Life Science Leader and Nice Insight. Our commitment to quality, productivity and willingness to customize anchor our position of service leadership in the CMO marketplace. We are proud of the work that we do to help pharmaceutical and biotechnology companies bring new medicines to market." Derek G. Hennecke — CEO and President